Medifast, Inc.
MED · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -15.3% | -8.8% | -2.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69.5% | 72.6% | 72.8% | 74.1% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 0.9% | 2.8% | 1.7% | 3.3% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | -2.5% | 2.3% | -0.7% | 0.7% |
| EPS Diluted | -0.21 | 0.22 | -0.07 | 0.07 |
| % Growth | -195.5% | 414.3% | -200% | – |
| Operating Cash Flow | $0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |